Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on the Treatment of Pediatric Hemophagocytic Lymphohistiocytosis Based on Cytokine Guided Risk Stratification：A Multicenter Randomized Controlled Study

NCT05491304 is registered in ClinicalTrials.gov with The Children's Hospital of Zhejiang University School of Medicine as lead sponsor.

NCT NCT05491304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05491304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on the Treatment of Pediatric Hemophagocytic Lymphohistiocytosis Based on Cytokine Guided Risk Stratification：A Multicenter Randomized Controlled Study
Lead sponsor
The Children's Hospital of Zhejiang University School of Medicine
Phase
Phase 4
Overall status
Unknown status
Start date
September 1, 2022
Completion date
December 31, 2025
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytokine storm, hemophagocytic lymphohistiocytoses